Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000914:Antibodies, Viral / Q000032:analysis; D002487:Centers for Disease Control and Prevention, U.S.; D003264:Containment of Biohazards; D004203:Disinfection / Q000379:methods; D006678:HIV / Q000276:immunology; D015483:HIV Antibodies; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007757:Laboratory Infection / Q000517:prevention & control*; D009316:National Institutes of Health (U.S.); D014481:United States
D000914:Antibodies, Viral; D015483:HIV Antibodies; D006514:Hepatitis B Surface Antigens